Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 1/2020

01-02-2020 | Abstract Set

Abstracts of 48th ESCP symposium on clinical pharmacy 23–25 October 2019, Ljubljana (Slovenia)

The digital revolution supporting clinical pharmacy through e-health, digital support systems, big data, and more

Published in: International Journal of Clinical Pharmacy | Issue 1/2020

Login to get access

Excerpt

Background and objective: Pharmacogenetics (PGx) is one of the determinants in personalized medicine. Summaries of Product Characteristics (SmPC) provide structured information to advice health care professionals for safe and effective drug use. Currently, in Swiss SmPCs no section is dedicated to PGx information. We analyzed (by natural language processing, NLP) PGx information in SmPCs of all Swiss drugs and described how PGx-relevant information and instructions are presented. …
Metadata
Title
Abstracts of 48th ESCP symposium on clinical pharmacy 23–25 October 2019, Ljubljana (Slovenia)
The digital revolution supporting clinical pharmacy through e-health, digital support systems, big data, and more
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00945-w

Other articles of this Issue 1/2020

International Journal of Clinical Pharmacy 1/2020 Go to the issue

Review Article

Effect of proton pump inhibitors on high-dose methotrexate elimination: a systematic review and meta-analysis

Short Research Report

Follow up survey for implementation of fixed-dosing of monoclonal antibodies

Research Article

Potential drug–drug interactions associated with clinical and laboratory findings at hospital admission

Research Article

Laxative use among older adults with intellectual disability: a cross-sectional observational study

Short Research Report

Hospital referral of older patients to community pharmacy: outcome measures in a feasibility study

Research Article

Patients’ perspectives on participation in clinical trials and subsequent ethical challenges in a hospital setting in Jordan
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits